Andrew Fein and Wainwright - Free people check

(1 - 16 from 24

)

Biotech Investor Realism with Andrew Fein | INN

investingnews.com

Expert healthcare company watcher Andrew Fein of H.C. Wainwright & Co. knows how the sausage is made in the stock analyst factory. And he doesn't pull any...

Biotech Investor Realism With Andrew Fein | Seeking Alpha

seekingalpha.com

Expert healthcare company watcher Andrew Fein of H.C. Wainwright & Co. knows how the sausage is made in the stock analyst factory. And he doesn't pull any punches: In ...

CCG Investor Relations Announces Company Presenters for NexGen Life...

www.prnewswire.com

Crocker Coulson of CCG Investor Relations will interview Andrew Fein, Managing Director & Senior Analyst at H.C. Wainwright on a panel on ...

Amarin Corp. PLC ADS (AMRN): H.C. Wainwright analyst Andrew Fein...

investorshub.advfn.com

Chris2125: H.C. Wainwright analyst Andrew Fein with a $ target following successful R-it. Downside is $

Amarin up premarket (NASDAQ:AMRN) | Seeking Alpha

seekingalpha.com

Amarin (AMRN) is up 16% premarket on increased volume. H.C. Wainwright analyst Andrew Fein upgraded the stock to "Buy" with a $10 price ...

TipRanks (@TipRanks) | Stocktwits

stocktwits.com

3-star analyst Andrew Fein from H.C. Wainwright reiterated a BUY rating on $INSM. Andrew has a +5.2% average return http://stks.co/q0dPV.

Andrew Fein - MD/Senior Analyst - H.C. Wainwright | LinkedIn

www.linkedin.com

View Andrew Fein's profile on LinkedIn, the world's largest professional community. Andrew has 7 jobs listed on their profile. See the complete profile on ...

Axovant Sciences Ltd. Common Sh (AXON) | Market Pulse ...

finance.yahoo.com

4-star analyst Andrew Fein from H.C. Wainwright rated $AXON w/a BUY. http://tipranks.com/experts/Andrew-Fein · stocktwits Fri, Jan 8, 2016, 02:41 PM EST.

Amarin Corporation plc (ADR) (AMRN) Cashes Out; Shares Tumble

finance.yahoo.com

Similarly, on November 2, H.C. Wainwright's Andrew Fein reiterated a ... Louise Chen and Andrew Fein have a yearly average loss of -4.3% ...

Andrew Fein | Analyst | Amarin Corporation plc

investor.amarincorp.com

Investor Relations / Andrew Fein. Andrew Fein. HC Wainwright. Shareholder Tools. Printed Materials. Printed Materials · Email Alerts. Email Alerts · Downloads ...

UPDATE: H.C. Wainwright & Co. Initiates Coverage On ...

finance.yahoo.com

From Yahoo Finance: In a note released Tuesday morning, H.C. Wainwright analyst Andrew Fein initiated a Buy on both Epizyme (NASDAQ: ...

Andrew Fein Archives | BioTuesdays

biotuesdays.com

Tweet H.C. Wainwright has initiated coverage of DBV Technologies (NASDAQ:DBVT; Euronext:DBV) with a “buy” rating and $50 price target, saying the company is an

PharmAthene, Inc (AMEX:PIP) - UPDATE: H.C. Wainwright Initiates...

www.benzinga.com

In a report published Monday, H.C. Wainwright & Co. analyst Andrew Fein initiated coverage on PharmAthene (NYSE: PIP) with a Buy rating and $4.00 price target. Fein

Andrew Fein H.C. Wainwright | INSM Message Board Posts

www.investorvillage.com

Insmed Incorporated Message board - Online Community of active, educated investors researching and discussing Insmed Incorporated Stocks.

Analyst Coverage | AC Immune SA

ir.acimmune.com

Firm, Analyst. H.C. Wainwright, Andrew Fein. Jefferies, Peter Welford. Leerink, Paul Matteis. AC Immune SA is followed by the analysts listed above. Please note ...

Meet Our Analysts – H.C. Wainwright & Co.

www.hcwainwright.com

Andrew Fein Managing Director, Senior Healthcare Analyst. Andrew Fein is a Managing Director focused on healthcare research at HCW. Mr. Fein has more ...

All web results to the name "Andrew Fein"

Related search requests for Andrew Fein

People
Forename "Andrew" (69761)
Name "Fein" (328)

sorted by relevance / date

Advanced Search

Search name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Andrew Fein and Wainwright Free People Check